Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erik Jongert

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
International Journal for Parasitology|August 13, 2008
Control of the risk of human toxoplasmosis transmitted by meatAize Kijlstra, Erik Jongert
Trends in Parasitology|October 28, 2008
Toxoplasma-safe meat: close to reality?Aize Kijlstra, Erik Jongert
Human Vaccines & Immunotherapeutics|September 22, 2017
Characterization of T-cell immune responses in clinical trials of the candidate RTS,S malaria vaccinePhilippe Moris, Erik Jongert, Robbert G van der Most
BMC Immunology|October 24, 2015
Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigensMarie-Cécile Mortier, Erik Jongert, Pascal Mettens, et al.
Veterinary Parasitology|July 9, 2008
The role of rodents and shrews in the transmission of Toxoplasma gondii to pigsAize Kijlstra, Bastiaan Meerburg, Jan Cornelissen, et al.
Vaccine|February 2, 2010
Functional characterization of in vivo effector CD4(+) and CD8(+) T cell responses in acute Toxoplasmosis: an interplay of IFN-gamma and cytolytic T cellsErik Jongert, Arnaud Lemiere, Jo Van Ginderachter, et al.
Journal of Immunological Methods|January 25, 2021
Whole blood can be used as an alternative to isolated peripheral blood mononuclear cells to measure in vitro specific T-cell responses in human samplesPhilippe Moris, Aurélie Bellanger, Opokua Ofori-Anyinam, et al.
Memorias Do Instituto Oswaldo Cruz|May 12, 2009
Vaccines against Toxoplasma gondii: challenges and opportunitiesErik Jongert, Craig W Roberts, Nicola Gargano, et al.
Elife|April 29, 2020
A delayed fractionated dose RTS,S AS01 vaccine regimen mediates protection via improved T follicular helper and B cell responsesSuresh Pallikkuth, Sidhartha Chaudhury, Pinyi Lu, et al.
International Journal of Pharmaceutics|October 16, 2003
Generation of Toxoplasma gondii GRA1 protein and DNA vaccine loaded chitosan particles: preparation, characterization, and preliminary in vivo studiesMaytal Bivas-Benita, Marleen Laloup, Soetkin Versteyhe, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
International Journal for Parasitology|August 13, 2008
Control of the risk of human toxoplasmosis transmitted by meatAize Kijlstra, Erik Jongert
Trends in Parasitology|October 28, 2008
Toxoplasma-safe meat: close to reality?Aize Kijlstra, Erik Jongert
Human Vaccines & Immunotherapeutics|September 22, 2017
Characterization of T-cell immune responses in clinical trials of the candidate RTS,S malaria vaccinePhilippe Moris, Erik Jongert, Robbert G van der Most
BMC Immunology|October 24, 2015
Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigensMarie-Cécile Mortier, Erik Jongert, Pascal Mettens, et al.
Veterinary Parasitology|July 9, 2008
The role of rodents and shrews in the transmission of Toxoplasma gondii to pigsAize Kijlstra, Bastiaan Meerburg, Jan Cornelissen, et al.
Vaccine|February 2, 2010
Functional characterization of in vivo effector CD4(+) and CD8(+) T cell responses in acute Toxoplasmosis: an interplay of IFN-gamma and cytolytic T cellsErik Jongert, Arnaud Lemiere, Jo Van Ginderachter, et al.
Journal of Immunological Methods|January 25, 2021
Whole blood can be used as an alternative to isolated peripheral blood mononuclear cells to measure in vitro specific T-cell responses in human samplesPhilippe Moris, Aurélie Bellanger, Opokua Ofori-Anyinam, et al.
Memorias Do Instituto Oswaldo Cruz|May 12, 2009
Vaccines against Toxoplasma gondii: challenges and opportunitiesErik Jongert, Craig W Roberts, Nicola Gargano, et al.
Elife|April 29, 2020
A delayed fractionated dose RTS,S AS01 vaccine regimen mediates protection via improved T follicular helper and B cell responsesSuresh Pallikkuth, Sidhartha Chaudhury, Pinyi Lu, et al.
International Journal of Pharmaceutics|October 16, 2003
Generation of Toxoplasma gondii GRA1 protein and DNA vaccine loaded chitosan particles: preparation, characterization, and preliminary in vivo studiesMaytal Bivas-Benita, Marleen Laloup, Soetkin Versteyhe, et al.
Pageof 6